PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2003

Primary Completion Date

July 31, 2006

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Enoxaparin sodium

Trial Locations (15)

Unknown

Sanofi-Aventis, Bridgewater

Sanofi-Aventis, North Ryde

Sanofi-Aventis, Vienna

Sanofi-Aventis, São Paulo

Sanofi-Aventis, Laval

Sanofi-Aventis, Bogotá

Sanofi-Aventis, Prague

Sanofi-Aventis, Mumbai

Sanofi-Aventis, Netanya

Sanofi-Aventis, Milan

Sanofi-Aventis, México

Sanofi-Aventis, Warsaw

Sanofi-Aventis, Johannesburg

Sanofi-Aventis, Seoul

Sanofi-Aventis, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY